Dr. James Tong of Tianyin Pharmaceuticals Discusses New Manufacturing Facility and Promising Future Milestones

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in modernized traditional Chinese medicines and branded generics.

Read more »

Tianyin Pharmaceuticals Receives China’s SFDA Approval for Its Anti-Diabetic Drug Gliclazide

In 2010, there were 95 million cases of diabetes in China, of which, 52 million and 43 million were found in rural and urban areas, respectively.

Read more »